Source: What Now News 24

On Sunday afternoon, a massive explosion at a pharmaceutical company in Taoyuan city in Taiwan injured two workers. Soon after the explosion, a fire broke out in the Sci Pharmtech Inc., which spread quickly to five nearby factories. It was reported that the explosion was heard from the Tamsui District in New Taipei City. After the explosion, thick black smoke was seen coming out from Sci Pharmtech Inc.

The firefighting department responded quickly to the fire, and contained the fire quickly. Firetrucks were deployed from the closely airport of Taoyuan airport. No flights have been affected by the thick black smoke.

Around 76 personnel, 28 fire equipment pieces and 2 ambulances were deployed to the area. The workers injured includes a Philippine worker. Both were taken to Chang Gung Memorial Hospital. The 30-year old Philippine worker is in critical condition after suffering third-degree burns to 90% of his body. He is currently intubated and treated at the specialist burn unit. The other worker, a Taiwanese, suffered a burn to one hand. He was held at the hospital for observation, but was than released after eight hours.

An investigation has been launched to determine the cause of the massive explosion. It has been reported by Liberty Times, that the pharmaceutical company produces hydroxychloroquine APIs. The company is considered to be the second largest hydroxychloroquine raw material supplier in the world.

On the same day, a Chinese aircraft carrier and four other navy warships passed through Taiwan strait in the direction of the South China Sea.

Update: Filipino worker succumbed to his injuries on Monday.









Related: Hydroxychloroquine factory on fire after explosion: Taiwan

The AMA Quietly Admits They Lied About Hydroxychloroquine

A massive hydroxychloroquine meta-analysis (156 studies) has just been updated (version 28!).It says that HCQ works beyond all statistical doubt.

Peer-reviewed hydroxychloroquine study finds 84% fewer hospitalizations among early treated outpatients

‘Only a one in 17 billion chance hydroxychloroquine doesn’t work’: medical professor

HCQ Protocols from America’s Frontline Doctors

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Stark madness to ban ivermectin

Buried in the note is the real reason for making ivermectin inaccessible – the fear that persons taking it ‘may elect not to be vaccinated as part of the national Covid-19 vaccination program’. This is outrageous. When someone is infected with Covid, it is too late to bother with vaccination. They need early treatment. To deny it to coerce them into accepting a vaccine, one of whose side-effects is death, is immoral.

Read More »

Australia’s TGA Bans GPs from Prescribing Ivermectin

Australia’s medicine and therapeutic regulatory, the Therapeutic Good Administration (TGA) recently took the gloves off with Ivermectin, the economical anti-parasitic drug associated with at least 63 completed clinical trials involving SARS-CoV-2, the virus behind COVID-19. Now TGA formally places a national prohibition on off-label prescribing of ivermectin to all general practitioners. A comparable move as to what TGA did with hydroxychloroquine in 2020. Clearly further evidence of tightening encroachment of the critically important doctor-patient treatment relationship allowing consent to medical treatment using off-label medications. Of course, this isn’t occurring in a vacuum—it’s part of an unfolding, integrated and what have the signs of a coordinated and orchestrated government action to stop any and all treatments other than those the government declares acceptable.

Read More »